(Q42489677)

1 November 2017

title

Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue (English)

1 reference

1 November 2017

1 reference

1 November 2017

Jorge S Reis-Filho

1 reference

1 November 2017

Alan Ashworth

1 reference

1 November 2017

Fernanda Milanezi

1 reference

1 November 2017

Dawn Steele

1 reference

1 November 2017

Silvana Di Palma

1 reference

1 November 2017

Robin L Jones

1 reference

1 November 2017

Kay Savage

1 reference

1 November 2017

Michelle James

1 reference

1 November 2017

publication date

1 February 2006

1 reference

1 November 2017

1 reference

1 November 2017

1 reference

1 November 2017

1 reference

1 November 2017

page(s)

307-319

1 reference

The nerve growth factor receptor gene is at human chromosome region 17q12-17q22, distal to the chromosome 17 breakpoint in acute leukemias

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

A region of the 75 kDa neurotrophin receptor homologous to the death domains of TNFR‐I and Fas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

The p75 neurotrophin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

A monoclonal antibody against nerve growth factor receptor. Immunohistochemical analysis of normal and neoplastic human tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Molecular characterization of the loss of p75(NTR) expression in human prostate tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

The p75(NTR) tumor suppressor induces caspase-mediated apoptosis in bladder tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Ibuprofen inhibits survival of bladder cancer cells by induced expression of the p75NTR tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Tumor necrosis factor receptor-associated death domain protein is involved in the neurotrophin receptor-mediated antiapoptotic activity of nerve growth factor in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Distribution and significance of 14-3-3sigma, a novel myoepithelial marker, in normal, benign, and malignant breast tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Current practical applications of diagnostic immunohistochemistry in breast pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Expression of luminal and basal cytokeratins in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Metaplastic carcinomas of the breast. II. Spindle cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Maspin expression in myoepithelial tumors of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

p63 expression in sarcomatoid/metaplastic carcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

Neurotrophin receptor p75(NTR) suppresses growth and nerve growth factor-mediated metastasis of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

7 January 2021

Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

7 January 2021

Detection of stromal invasion in breast cancer: the myoepithelial markers.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

7 January 2021

Metaplastic carcinomas of the breast. III. Carcinosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

7 January 2021

Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

7 January 2021

Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

7 January 2021

An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

7 January 2021

CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

7 January 2021

Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

7 January 2021

CD34, CD117, and actin expression in phyllodes tumor of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

7 January 2021

Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

7 January 2021

Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 25 patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800542

7 January 2021

10.1038/MODPATHOL.3800542

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

1005893967

0 references

1 reference